Sustainable Medicines

Pfizer seeks to leverage our strengths in scientific innovation to reduce the environmental impact of our medicines throughout the product life cycle.

 

sustainable medicines

 

Unleashing the power of our scientific core on the environmental sustainability challenge has enabled the development of effective decision-making tools and selective investment in contemporary manufacturing technologies, increasing efficiency and reducing time to market.1

 

AMR Industry Alliance Roadmap

Recognising the threat to human health from antimicrobial resistance (AMR), we remain committed to the AMR Industry Alliance (AMRIA) roadmap that demonstrates responsible manufacturing of our products and provides greater transparency to our actions. Our progress in driving a responsible manufacturing strategy, including risk assessments against science-based discharge targets, was positively recognised through the 2020 Access to Medicine AMR Benchmark. We remain committed to our goal of meeting industry targets no later than 2025.

 

References

  1. Pfizer Environmental, Social & Governance Report 2020.

 

PP-PFE-GBR-3937 / September 2021